收藏切换
The changes of alveolar type Ⅱ epithelial cells in the process of idiopathic pulmonary fibrosis
收藏切换
Guojie LI1, 2, Yifang DENG1, 2, Minyu LIU1, 2, *
World Clinical Drug | 2024, 45(11) : 1187 - 1191
Less
收藏切换
World Clinical Drug | 2024, 45(11): 1187-1191
• Review •
The changes of alveolar type Ⅱ epithelial cells in the process of idiopathic pulmonary fibrosis
Full
Guojie LI1, 2, Yifang DENG1, 2, Minyu LIU1, 2, *
Affiliations
  • 1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai 200437, China
Published: 2024-11-10 doi: 10.13683/j.wph.2024.11.012
Outline
收藏切换

Alveolar type Ⅱ epithelial cells (AT2), as alveolar epithelial stem cells, possess significant proliferative and differentiation potential, plays a crucial role in maintaining lung homeostasis and the repair of lung injury. Studies have shown that idiopathic pulmonary fibrosis would occur when the normal function of AT2 is disrupted and transforms into fibrosis-promoting phenotype. Being located on the mucosal surface, AT2 is inevitably exposed to environmental stress, which can have long-lasting effects and ultimately promote the development of fibrosis. At the same time, genetic mutations may also lead to impaired AT2 function and the occurrence of pulmonary fibrosis. Additionally, aging is also one of the significant factors that increase the pathological changes in AT2. The article discussed the regeneration process of AT2 and the pathways that lead to AT2 aging, apoptosis, and dysfunction.

alveolar epithelial cells  /  pulmonary fibrosis  /  stem cell regeneration  /  cellular senescence  /  apoptosis
李国杰, 邓轶方, 刘珉宇. 肺泡Ⅱ型上皮细胞在特发性肺纤维化过程中的变化. 世界临床药物, 2024 , 45 (11) : 1187 -1191 . DOI: 10.13683/j.wph.2024.11.012
Guojie LI, Yifang DENG, Minyu LIU. The changes of alveolar type Ⅱ epithelial cells in the process of idiopathic pulmonary fibrosis[J]. World Clinical Drug, 2024 , 45 (11) : 1187 -1191 . DOI: 10.13683/j.wph.2024.11.012
Year 2024 volume 45 Issue 11
18
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.11.012
  • Receive Date:2024-05-13
  • Online Date:2026-11-17
  • Published:2024-11-10
Article Data
Affiliations
History
  • Received:2024-05-13
Funding
Affiliations
    1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
    2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai 200437, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.11.012
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT